Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tatjana Vlajnic

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Pathologie (Heidelberg, Germany)|July 3, 2024
[New edition of the Paris classification 2022: What is new?]Tatjana Vlajnic, Lukas Bubendorf
Der Pathologe|February 8, 2022
[Diagnostic and predictive markers in urinary tract cytology]Tatjana Vlajnic, Lukas Bubendorf
Pathology|November 25, 2020
Molecular pathology of prostate cancer: a practical approachTatjana Vlajnic, Lukas Bubendorf
Methods in Molecular Biology (Clifton, N.J.)|May 23, 2018
Protocols for Tissue Microarrays in Prostate Cancer StudiesTatjana Vlajnic, Serenella Eppenberger-Castori, Lukas Bubendorf
Journal of Clinical Pathology|August 31, 2019
The Paris System for reporting urinary cytology in daily practice with emphasis on ancillary testing by multiprobe FISHTatjana Vlajnic, André Gut, Spasenija Savic, et al.
World Journal of Gastroenterology|July 2, 2010
Annular pancreas associated with duodenal carcinomaEnrico Brönnimann, Silke Potthast, Tatjana Vlajnic, et al.
Journal of Cancer|October 18, 2021
L1CAM is not a reliable predictor for lymph node metastases in endometrial cancer, but L1CAM positive patients benefit from radiotherapyDeborah Zeiter, Tatjana Vlajnic, Andreas Schötzau, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|September 27, 2022
PD-L1 Expression in Triple-negative Breast Cancer-a Comparative Study of 3 Different AntibodiesTatjana Vlajnic, Fabienne Baur, Savas D Soysal, et al.
Cancers|February 15, 2022
An Integrated Epigenomic and Genomic View on Phyllodes and Phyllodes-like Breast TumorsJuergen Hench, Tatjana Vlajnic, Savas Deniz Soysal, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|September 23, 2021
High Inter- and Intratumoral Variability of Ki67 Labeling Index in Newly Diagnosed Prostate Cancer with High Gleason ScoresTatjana Vlajnic, Patrik Brunner, Serenella Eppenberger-Castori, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Pathologie (Heidelberg, Germany)|July 3, 2024
[New edition of the Paris classification 2022: What is new?]Tatjana Vlajnic, Lukas Bubendorf
Der Pathologe|February 8, 2022
[Diagnostic and predictive markers in urinary tract cytology]Tatjana Vlajnic, Lukas Bubendorf
Pathology|November 25, 2020
Molecular pathology of prostate cancer: a practical approachTatjana Vlajnic, Lukas Bubendorf
Methods in Molecular Biology (Clifton, N.J.)|May 23, 2018
Protocols for Tissue Microarrays in Prostate Cancer StudiesTatjana Vlajnic, Serenella Eppenberger-Castori, Lukas Bubendorf
Journal of Clinical Pathology|August 31, 2019
The Paris System for reporting urinary cytology in daily practice with emphasis on ancillary testing by multiprobe FISHTatjana Vlajnic, André Gut, Spasenija Savic, et al.
World Journal of Gastroenterology|July 2, 2010
Annular pancreas associated with duodenal carcinomaEnrico Brönnimann, Silke Potthast, Tatjana Vlajnic, et al.
Journal of Cancer|October 18, 2021
L1CAM is not a reliable predictor for lymph node metastases in endometrial cancer, but L1CAM positive patients benefit from radiotherapyDeborah Zeiter, Tatjana Vlajnic, Andreas Schötzau, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|September 27, 2022
PD-L1 Expression in Triple-negative Breast Cancer-a Comparative Study of 3 Different AntibodiesTatjana Vlajnic, Fabienne Baur, Savas D Soysal, et al.
Cancers|February 15, 2022
An Integrated Epigenomic and Genomic View on Phyllodes and Phyllodes-like Breast TumorsJuergen Hench, Tatjana Vlajnic, Savas Deniz Soysal, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|September 23, 2021
High Inter- and Intratumoral Variability of Ki67 Labeling Index in Newly Diagnosed Prostate Cancer with High Gleason ScoresTatjana Vlajnic, Patrik Brunner, Serenella Eppenberger-Castori, et al.
Pageof 6